You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國醫療集團(08225.HK)年度溢利增長20%至2779萬元 不派息
格隆匯 03-11 07:33

格隆匯3月11日丨中國醫療集團(08225.HK)公佈,截至2019年12月31日止年度,公司收入6321.6萬元人民幣,同比增長6.1%;年度溢利2779萬元,同比增長20%;每股盈利2.8仙人民幣,不派息。

收入中上市後研究及學術推廣服務收入約人民幣5536萬元,佔總收入比例為87.57%;合約臨牀研究服務收入約人民幣元7.2萬元,佔總收入之比例為0.1%;提供合約藥品開發服務約人民幣778.4萬元,佔總收入比例為12.31%。集團極力打造的四大成長驅動平台之一臨牀科研為依託的終端臨牀醫學研究式推廣即上市後研究及學術推廣服務得到市場的廣泛認可;收入貢獻佔比為87.57%;提供合約藥品開發服務也有比較大幅度的增長,收入貢獻佔比為12.31%,比去年增長3,226%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account